Why is Pharmaids Pharma falling/rising?

As of 29-Jul, Pharmaids Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 64.98, reflecting a decrease of 0.53 or 0.81%. The stock has underperformed its sector by 2.22% today and has been on a consecutive downward trend for the last two days, with a total decline of 2.27% during this period. Despite a strong performance over the past year, where it generated a return of 48.53%, the company is facing significant challenges, including operating losses and a weak long-term fundamental strength, as indicated by a negative EBITDA and a poor EBIT to Interest ratio of -8.39. Additionally, the company's recent financial results show a concerning drop in profit after tax and profit before tax, further contributing to investor apprehension.
In the broader market context, the stock's short-term performance has been notably worse than the benchmark, with a 1-week return of -3.04% compared to the Sensex's decline of only 1.03%. This underperformance is compounded by a decrease in investor participation, as evidenced by a 31.83% drop in delivery volume against the 5-day average. While the stock has shown remarkable growth over longer periods, such as a 430.02% increase over three years, the current operating losses and high debt-equity ratio signal potential risks that may deter investors in the short term.